Melatonin and Cancer Hallmarks DOI Creative Commons
Wamidh H. Talib

Molecules, Journal Year: 2018, Volume and Issue: 23(3), P. 518 - 518

Published: Feb. 26, 2018

Melatonin is a natural indoleamine produced by the pineal gland that has many functions, including regulation of circadian rhythm. Many studies have reported anticancer effect melatonin against myriad cancer types. Cancer hallmarks include sustained proliferation, evading growth suppressors, metastasis, replicative immortality, angiogenesis, resisting cell death, altered cellular energetics, and immune evasion. activity mediated interfering with various hallmarks. This review summarizes role in each hallmark. The discussed this should serve as solid foundation for researchers physicians to support basic clinical on promising agent.

Language: Английский

Targeting CDK4 and CDK6 in cancer DOI
Shom Goel, Johann S. Bergholz, Jean J. Zhao

et al.

Nature reviews. Cancer, Journal Year: 2022, Volume and Issue: 22(6), P. 356 - 372

Published: March 18, 2022

Language: Английский

Citations

321

The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival DOI
Haizhen Wang, Brandon Nicolay,

Joel M. Chick

et al.

Nature, Journal Year: 2017, Volume and Issue: 546(7658), P. 426 - 430

Published: June 1, 2017

Language: Английский

Citations

306

Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition DOI Creative Commons
Mónica Álvarez‐Fernández, Marcos Malumbres

Cancer Cell, Journal Year: 2020, Volume and Issue: 37(4), P. 514 - 529

Published: April 1, 2020

Language: Английский

Citations

283

Interconnection between Metabolism and Cell Cycle in Cancer DOI Creative Commons
Philippe Icard, Ludovic Fournel, Zherui Wu

et al.

Trends in Biochemical Sciences, Journal Year: 2019, Volume and Issue: 44(6), P. 490 - 501

Published: Jan. 15, 2019

Language: Английский

Citations

270

Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy DOI
Jonathan Chou, David A. Quigley, Troy M. Robinson

et al.

Cancer Discovery, Journal Year: 2020, Volume and Issue: 10(3), P. 351 - 370

Published: Feb. 18, 2020

Drugs targeting the cell cycle-regulatory cyclin-dependent kinase (CDK) 4 and 6 have been approved for treatment of hormone receptor-positive breast cancer, inhibitors other cell-cycle CDKs are currently in clinical trials. Another class CDKs, transcription-associated including CDK7, CDK8, CDK9, CDK12 CDK13, critical regulators gene expression. Recent evidence suggests several novel functions these regulation epigenetic modifications, intronic polyadenylation, DNA-damage responses, genomic stability. Here, we summarize our current understanding transcriptional their utility as biomarkers, potential therapeutic targets. SIGNIFICANCE: CDK CDK4 CDK6 Several studies now point to opportunities by inhibiting well vulnerabilities with PARP immunotherapy tumors deficient CDKs.

Language: Английский

Citations

235

Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer DOI Creative Commons
Víctor Quereda,

Simon Bayle,

Francesca Vena

et al.

Cancer Cell, Journal Year: 2019, Volume and Issue: 36(5), P. 545 - 558.e7

Published: Oct. 24, 2019

Language: Английский

Citations

231

Hepatocellular Carcinoma: Etiology and Current and Future Drugs DOI Creative Commons
Aastha Jindal, Anusha Thadi,

Kunwar Shailubhai

et al.

Journal of Clinical and Experimental Hepatology, Journal Year: 2019, Volume and Issue: 9(2), P. 221 - 232

Published: Jan. 27, 2019

Hepatocellular carcinoma (HCC) is swiftly increasing in prevalence globally with a high mortality rate. The progression of HCC patients induced advanced fibrosis, mainly cirrhosis, and hepatitis. absence proper preventive or curative treatment methods encouraged extensive research against to develop new therapeutic strategies. Food Drug Administration-approved Nexavar (sorafenib) used the unresectable HCC. In 2017, Stivarga (regorafenib) Opdivo (nivolumab) got approved for after being treated sorafenib, 2018, Lenvima (lenvatinib) But, owing rapid drug resistance development toxicities, these options are not completely satisfactory. Therefore, there an urgent need systemic combination therapies that target different signaling mechanisms, thereby decreasing prospect cancer cells developing treatment. this review, etiology strategies include currently drugs other potential candidates such as Milciclib, palbociclib, galunisertib, ipafricept, ramucirumab evaluated.

Language: Английский

Citations

230

Structural insights into the functional diversity of the CDK–cyclin family DOI Creative Commons
D.J. Wood, Jane Endicott

Open Biology, Journal Year: 2018, Volume and Issue: 8(9)

Published: Sept. 1, 2018

Since their characterization as conserved modules that regulate progression through the eukaryotic cell cycle, cyclin-dependent protein kinases (CDKs) in higher cells are now also emerging significant regulators of transcription, metabolism and differentiation. The cyclins, though originally characterized CDK partners, have CDK-independent roles include regulation DNA damage repair transcriptional programmes direct differentiation, apoptosis metabolic flux. This review compares structures members cyclin families determined by X-ray crystallography, considers what mechanistic insights they provide to guide functional studies distinguish CDK- cyclin-specific activities. Aberrant activity is a hallmark number diseases, structural can important identify novel routes therapy.

Language: Английский

Citations

223

Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs DOI
Robert Roskoski

Pharmacological Research, Journal Year: 2016, Volume and Issue: 107, P. 249 - 275

Published: March 16, 2016

Language: Английский

Citations

219

Mechanisms Used by Plants to Cope with DNA Damage DOI
Zhubing Hu, Toon Cools, Lieven De Veylder

et al.

Annual Review of Plant Biology, Journal Year: 2015, Volume and Issue: 67(1), P. 439 - 462

Published: Dec. 9, 2015

Because the genome stores all genetic information required for growth and development, it is of pivotal importance to maintain DNA integrity, especially during cell division, when prone replication errors damage. Although over last two decades has become evident that basic cycle toolbox plants shares several similarities with those fungi mammals, appear have evolved a set distinct checkpoint regulators in response different types stress. This might be consequence plants' sessile lifestyle, which exposes them unique damage-inducing conditions. In this review, we highlight stress typically experience describe plant-specific molecular mechanisms control division these stresses.

Language: Английский

Citations

215